Development of a novel calcium channel therapeutic for opioid use disorder - vivreon biosciences, LLC 4940 carroll canyon RD., STE. 110 SAN diego, CA 92121
Active Project Grant Awarded Last action
- Award ID
- R44DA058467
- Recipient
-
Vivreon Biosciences LLC UEI P935LHN98ZV9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,623,065
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date 83% complete
- Originally
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $1,097,854 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,401,740 | |
| Amendment | $1,401,740 | |
| Amendment | $1,401,740 | |
| Original award | $319,991 |
Quick answers
Who received award R44DA058467?
R44DA058467 was awarded to Vivreon Biosciences LLC by National Institute on Drug Abuse (National Institutes of Health) on July 15, 2023.
How much is award R44DA058467 worth?
$5,623,065 has been obligated on R44DA058467.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award